Page 267 Cite

Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.

×

Appendix C

Public Meeting Agenda

COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C

National Academy of Sciences Building, 2100 Constitution Avenue NW
Washington, DC 20001

June 8, 2016
Room 120

PHASE TWO ORIENTATION

9:00-9:15	Welcome and Introductions
9:00-9:15	Brian Strom, Committee Chair
9:15-10:15	Sponsor Orientation to Phase Two
	John Ward, Director, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC)
	Nadine Gracia, Deputy Assistant Secretary for Minority Health, Office of Minority Health, Department of Health and Human Services (HHS)
	Michael Fried, Board Member, American Association for the Study of Liver Diseases
	Ryan Clary, Executive Director, National Viral Hepatitis Roundtable
10:15-10:30	Break

Page 268 Cite

Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.

×

SCREENING AND REFERRALS TO CARE

10:30-12:00	Panel Discussion on Novel Strategies for Testing and Follow-Up
	Kathleen Maurer, Moderator
	Sabrina Assoumou, Assistant Professor of Medicine, Boston University Alicia Ifkovic-Mau, Correctional Counselor Supervisor, Department of Corrections, State of Connecticut William Stauffer, Professor of Medicine and Pediatrics, Division of Infectious Diseases and International Medicine, University of Minnesota David Thomas, Director, Division of Infectious Diseases, Johns Hopkins School of Medicine
12:00-1:00	Lunch

INNOVATIVE FINANCING FOR HEPATITIS C TREATMENTS

1:00-2:30	Panel Discussion on Paying for Cures
	Neeraj Sood, Moderator
	Tim Gronniger, Deputy Chief of Staff, Centers for Medicare & Medicaid Services Steve Miller, Chief Medical Officer, Express Scripts Coy Stout, Vice President, Managed Markets, Gilead
2:30-2:45	Break
2:45-4:15	Panel Discussion on Hepatitis C Treatment in Government Programs
	Brian Strom, Moderator
	John Coster, Director, Division of Pharmacy, Center for Medicaid and Children’s Health Insurance Program (CHIP) Services, Centers for Medicare & Medicaid Services Kimberley Lenz, Clinical Pharmacy Manager, MassHealth Robert Zavoski, Medical Director, Connecticut Department of Social Services

Page 269 Cite

Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.

×

4:15-4:45	Public Health and Drug Pricing: Policy Solutions for Population Coverage
4:15-4:45	Joshua Sharfstein, Professor of the Practice, Johns Hopkins Bloomberg School of Public Health
5:00	Adjourn
6:30	Working dinner for committee and staff at Circle Bistro

June 9, 2016
Members’ Room

INTERNATIONAL PROGRAMS ON VIRAL HEPATITIS

9:00-9:05	Welcome
9:00-9:05	Brian Strom, Committee Chair
9:05-9:35	Global Momentum for Viral Hepatitis Elimination
9:05-9:35	Stefan Wiktor, Team Lead, Global Hepatitis Program, World Health Organization (WHO)
9:40-10:10	An Australian Perspective on Hepatitis Elimination
9:40-10:10	Ben Cowie, Director, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, University of Melbourne
10:10-10:30	Break

HARM REDUCTION AND NEEDLE EXCHANGE

10:30-12:00	Panel Discussion on Harm Reduction in Rural Areas and Small Towns
	Shruti Mehta, Moderator
	Jerome Adams, Health Commissioner, Indiana State Department of Health Jennifer Havens, Associate Professor, Center for Drug and Alcohol Research, University of Kentucky College of Medicine Robin Pollini, Senior Research Scientist, Pacific Institute for Research and Evaluation
12:00-1:00	Lunch

Page 270 Cite

Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.

×

INTEGRATING CLINICAL AND PUBLIC HEALTH DATA

1:00-2:30	Panel Discussion on Using Electronic Records for Clinical Medicine and Public Health
	Grace Wang, Moderator
	Jeff Duchin, Professor in Medicine, Division of Allergy and Infectious Diseases, University of Washington Michael Klompas, Associate Professor and Infectious Diseases Specialist, Harvard Medical School and Harvard Pilgrim Health Care Institute Chia Wang, Infectious Diseases Specialist and Clinical Associate Professor of Medicine, Virginia Mason Medical Center, International Community Health Services and University of Washington